— Know what they know.
Not Investment Advice

IIN NASDAQ

IntriCon Corporation
1W: +0.9% 1M: +0.8% 3M: +44.1% 1Y: +1.1% 3Y: -2.8% 5Y: +218.9%
$24.23
Last traded 2022-05-24 — delisted
NASDAQ · Healthcare · Medical - Instruments & Supplies

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$125M +21.8% ▲
5Y CAGR: +13.0%
Gross Profit
$31M +19.9% ▲
5Y CAGR: +13.0%
Operating Income
$50K +101.6% ▲
Net Income
-$64K +97.5% ▲
EPS (Diluted)
$-0.01 +97.5% ▲
EBITDA
$6M +159.0% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2017FY2018FY2019FY2020FY2021
Revenue$88M$116M$113M$103M$125M
YoY Growth+29.9%+31.9%-2.5%-9.4%+21.8%
Cost of Revenue$62M$79M$83M$77M$94M
Gross Profit$26M$37M$31M$26M$31M
Gross Margin30.0%31.9%27.3%25.5%25.1%
R&D Expenses$4M$5M$4M$5M$5M
SG&A Expenses$20M$25M$25M$22M$25M
Operating Expenses$24M$30M$29M$28M$31M
Operating Income$2M$7M-$2M-$3M$50K
Operating Margin2.5%6.1%-1.8%-3.0%0.0%
Interest Expense$716K$314K$0$0$21K
Income Before Tax$1M$6M-$2M-$2M$71K
Tax Expense$8K$484K$201K$61K$135K
Net Income$2M$6M-$4M-$3M-$64K
Net Margin2.0%4.8%-3.3%-2.5%-0.1%
EPS (Diluted)$0.25$0.64$-0.43$-0.28$-0.01
EBITDA$5M$9M-$299K$2M$6M
Shares Outstanding7M9M9M9M9M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms